10,000 Healthcare Professionals from 117 Countries and Julissa's Keynote Session at GSK's Vaccine Virtual Days 2024

Unlocking the Power of Vaccination: 10,000 Healthcare Professionals from 117 Countries and Julissa's Keynote Session at GSK's Vaccine Virtual Days 2024

The GSK For US Healthcare Professionals Vaccine Virtual Days (VVD) 2024 was a resounding success, marking a pivotal moment in the global conversation about adult immunization.

This year's event, with a strong focus on adult immunization, showcased an impressive lineup of discussions and presentations, driving advancements in healthcare and contributing significantly to the Decade of Healthy Aging initiative by the World Health Organization (WHO).

A Global Stage for Adult Immunization

One of the most noteworthy achievements of VVD2024 was its global reach and impact. With over 10,000 healthcare professionals registering from 117 countries, it became the largest external engagement event ever hosted by GSK. The event's significance was further underscored by its feature on the United Nations' Decade of Healthy Aging webpage, recognizing VVD as a valuable contribution to this global initiative.

Julissa's Keynote: Unlocking the Power of Vaccination

A standout moment at VVD2024 was the keynote speech by Julissa, whose participation and insights were instrumental in shaping the event's success. Her session focused on unlocking the power of vaccination, delving into various critical aspects such as:

The Value of Adult Immunization: Highlighting the importance of vaccinations in enhancing the health and well-being of adults, especially in the context of aging populations.

Julissa's keynote was not just a highlight but a catalyst for meaningful discussions among attendees, enriching the overall dialogue and fostering a deeper understanding of adult immunization's importance.

The results of VVD2024 are a testament to its success and impact:

• Increased Awareness: The level of awareness regarding the importance of adult immunization among participants increased by 27%.

• Improved Decision-Making Comfort: There was a 29% improvement in participants' comfort in making educated decisions with patients about vaccinations.

• Enhanced Confidence: Participants' confidence in recognizing the importance of adult immunization and the need to enhance vaccine responses in older adults saw a 22% increase.

These outcomes highlight a significant shift in the understanding and approach to adult immunization, demonstrating the event's effectiveness in educating and empowering healthcare professionals worldwide.

A Milestone in Healthcare Collaboration

The success of VVD2024 is not just measured by the numbers but by the collaborative spirit it fostered. The event brought together policymakers, academia, researchers, and clinical experts, creating a robust platform for collective effort towards advancing adult immunization and healthy aging. This collaboration marks a groundbreaking partnership and sets a precedent for future initiatives in healthcare.

Looking Forward

As we reflect on the achievements of Vaccine Virtual Days 2024, we are filled with gratitude for the outstanding contributions from all participants, especially Julissa, whose keynote set the tone for a transformative event. The discussions and insights shared have left a lasting impact, and we look forward to future collaborations to continue making a positive difference in the lives of patients worldwide.

Together, we are unlocking the power of vaccination and paving the way for a healthier, more resilient future for adults across the globe. Thank you for being a part of this journey and for your unwavering dedication to advancing healthcare.